ABBV34:BVMF
Abbvie Inc BDR
R$84.01
arrow_upward
+1.95%(+1.61) 1D
Sep 14, 5:06:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV34...
Open
R$83.72
High
R$85.35
Low
R$83.72
Mkt. cap
462.58B
Avg. vol.
1.12K
Volume
349.00
52-wk high
R$86.95
52-wk low
R$58.53
Shares outstanding
1.77B
No. of employees
57K
Open
R$83.72
High
R$85.35
Low
R$83.72
Mkt. cap
462.58B
Avg. vol.
1.12K
Volume
349.00
52-wk high
R$86.95
52-wk low
R$58.53
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
6 hours ago
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
TIKR.com
·
1 day ago
AbbVie Stock Rises as Management Details Pipeline Momentum at Wells Fargo Healthcare Conference
Simply Wall Street
·
2 days ago
Could Atogepant Trial Win Change The Bull Case For AbbVie Stock (ABBV)?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Inc BDR
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com